Introduction
Unlike substances such as cocaine and heroin, euphoric effects of nicotine are mild.
Despite this, nicotine is highly addictive [1] . Animal studies indicate that reinforcing properties of nicotine may be mediated through enhancement of salience of non-drugrelated experiences; nicotine self-administration is associated with increased responsiveness to non-drug reward [2] , while nicotine withdrawal is associated with refractoriness to reward [3] . Phasic dopamine release modulates salience attribution and motivation [4, 5] , and nicotine may increase appetitive responding for non-drug incentives via activation of presynaptic nicotinic receptors (nAChR's) on mesocorticolimbic dopaminergic neurons [1, 2] . Consistent with this hypothesis, nicotine enhances the incentive value of monetary reward in smokers following overnight abstinence [6] . Whether nicotine enhances responding for non-drug incentives in the absence of potentially confounding effects of nicotine withdrawal or chronic effects of nicotine on reward responsiveness is unknown. We conducted a randomized, doubleblind, placebo-controlled crossover study of a single dose of transdermal nicotine in healthy adult non-smokers to determine if responsiveness to non-drug reward is increased in non-smokers acutely treated with nicotine. This was an ancillary study conducted in conjunction with a larger study of the effect of nicotine on cognitive performance in nonsmokers [7] .
Methods
The study took place at an urban community mental health clinic (Freedom Trail Clinic) and was approved by Institutional Review Boards of the Massachusetts General Hospital and the Massachusetts Department of Mental Health. All participants were assessed by a doctoral level investigator as competent to consent and provided written informed consent.
Participants:
Adults, aged 18-60, were recruited via local press advertisement and were eligible to participate if they were non-smokers for ≥3 months with salivary cotinine < 10 ng/ml Depression Inventory (BDI) at baseline and were randomized by computer-generated, random number assignment with concealed allocation for order of receiving active or placebo patches. The randomization procedure was conducted by a staff member from another research team, was concealed using opaque envelopes and all study investigators, staff and subjects were blind to group allocation for the duration of the study. Participants then attended two study visits, separated by 1-2 weeks, at which they wore two 7 mg (Nicoderm CQ) nicotine or identical placebo patches (Alza Corp., Mountain View, CA).
We elected to use two 7 mg patches instead of a single 14 mg patch to allow for dose reduction if participants experienced adverse effects. Following application of patches, participants had lunch and watched an affectively neutral or slightly positive movie of their choice. Tests of reward responsiveness were performed after three hours. At the end of the testing period, blood was drawn for serum nicotine concentration and patches were removed.
Tasks and Procedures:
A signal detection task, designed to measure shift in responding toward a differentially (more) rewarded stimulus, was administered twice, in two separate sessions, 3 hours after nicotine patch and after placebo patch application, as an objective measure of reward responsiveness [8] [9] [10] . This operationalization of response bias as a measure of reward responsiveness fits with the view that reinforcers are stimuli that increase frequency of responding [11] . For each trial, participants were asked to choose which of two stimuli (short or long mouth) was presented on a previously mouthless cartoon face by making a corresponding response on a keyboard. At each session, participants performed three blocks, each containing 50 trials of the short and 50 trials of the long mouth. Critically, the difference between mouth sizes (11.5 mm vs. 13 mm) and the stimulus exposure time (100 ms) is small, making the participants' choice difficult, and thus allowing the development of a response bias. In line with prior studies [10] , an asymmetric reinforcer ratio was used to elicit a response bias. Correct identification of one stimulus was rewarded ("Correct!! You won 5 Cents") three times more frequently ("rich stimulus") compared to correct identification of the other stimulus ("lean stimulus"). To expose each subject to the intended 3:1 reward ratio, only 40 correct trials (30 rich, 10 lean) were rewarded in each block. Choice of rich stimuli (long vs. short mouth) was counterbalanced between participants and across visits (e.g. if the long mouth was the rich stimulus at the first visit then the short mouth would be the rich stimulus at the second). Before the task, participants were instructed to try to win as much money as possible and that the money they win will be given to them to keep. They were specifically instructed that not all correct responses would receive a reward feedback, and that lack of feedback did not indicate inaccuracy and that they receive no feedback for errors. They were not informed, however, about the differential reward schedule. Prior studies with this paradigm in healthy subjects have shown that unequal frequency of reward to correct responses to the more frequently (rich) vs. less frequently rewarded (lean) stimulus produces a systematic preference for the response paired with the more frequent reward, which typically increases across blocks [8, 12, 13] . Performance is analyzed in terms of response bias, an index of the tendency to choose the more rewarded stimulus and an objective assessment of reward responsiveness. Control analyses are performed for accuracy, discriminability, and reaction time (RT), which provide information about overall task performance. Response bias (log b) and discriminability (log d) were computed as follows [10] :
As evident from the formula, a high response bias is observed if a participant has a high number of correct identifications for the more frequently rewarded (rich) stimulus and a low number of correct identifications for the lean stimulus. Discriminability, which assessed participants' ability to distinguish between the two stimuli, was used as an indicator of task difficulty. Participants also completed the State Trait Anxiety Inventory (state form) and other cognitive tests reported separately [7] .
Data Reduction and Analyses:
Trials with RT <150 ms or >2500 ms and/or >3 standard deviations from the mean computed for each subject individually after applying a logarithmic transformation were identified as outlier responses and excluded. There were a priori criteria to exclude participants with accuracy of less than chance (50%) or total rewards of <30 in any block.
Data from two participants were removed by these criteria. Data were assessed for distributional properties prior to analysis and one variable (RT) required log transformation to meet criteria for normal distribution (pre-transformation skew=1.71 + 0.31, kurtosis = 3.70 +0.61; post-transformation skew= 0.97+0.31, kurtosis=1.27 +0.61).
Identical split-plot repeated measures analyses of variance (ANOVA) were performed for response bias and discriminability with Treatment (nicotine, placebo) and Block (1, 2 and 3) included as within-subject factors, and Order of Drug Administration as the betweensubject factor. For analyses of RT and accuracy, Stimulus Type (lean vs. rich) was included as an additional within-subject factor. In case of significant ANOVA effects, posthoc Newman-Keuls tests were performed. Greenhouse-Geisser corrections were employed when Mauchley's test of sphericity was significant. Data are presented as mean + standard deviation. Analyses were performed using SPSS for Windows 10 (SPSS Inc.) and Statistica.
Results
All study procedures took place between January 2005 and July 2006. Thirty-two participants completed all study procedures (i.e., a placebo and nicotine session). Data for two participants were lost (they met a priori criteria for exclusion). Data from 30 participants are presented. See Supplementary Material 1. Demographic characteristics are given in Table 1 . Serum nicotine levels were higher in the nicotine condition (7.5 vs <0.5 ng/ml, t=12.6, p<0.0001).
Response Bias:
As shown in Figure 1 , nicotine increased responding to reward (main effect F 1,28 =8.18, p=0.008). Interestingly, while there was no overall interaction between Treatment (between session factor) and Block (within session factor) ( Because of lasting effects of nicotine on response bias observed in this study and reports of persistent effects of chronic nicotine use on cognitive function [14] , analyses were repeated in a subsample of 23 participants who reported never smoking a single cigarette.
The effect of nicotine on response bias was unchanged; the main effect of Treatment remained significant (F 1,21 =13.79, p=0.001).
Control Analyses:
Accuracy:
The Treatment (placebo, nicotine) by Block 
Adverse Events:
State anxiety was higher in the nicotine condition (STAI=33.5+9.3 vs. 29.7+6.5, t =-2.5, p=0.02). Thirteen participants experienced nausea and 4 required dose reduction to 7 mg.
Other adverse effects included skin irritation (n=12), dizziness (n=9), headache (n=8) and palpitations (n=1). No significant correlation emerged between number and severity of side effects and change in response bias between blocks 1 and 3.
Discussion
This is the first study to demonstrate that nicotine can enhance responding for a positive response cue and monetary reward in non-nicotine dependent as well as nicotine-naïve humans. These data suggest that nicotine increases salience of rewarding stimuli in the environment, a property that may contribute to initial development and maintenance of nicotine dependence. Cigarette smoking takes place in the context of many daily activities, and nicotine may increase the salience of environmental reinforcers in these situations. If attempts at smoking cessation are associated with loss of salience of numerous everyday pleasurable experiences then this may make smoking abstinence more difficult to sustain, triggering relapse.
Striatal dopamine and acetylcholine release are believed to play an important role in probabilistic reward-based learning and attention, signaling behavioral significance of environmental events and influencing decision making or choice [15] [16] [17] [18] [19] . The elimination of cholinergic neurons in the striatum results in impairments in reward-related learning [20] , and phasic activation of both striatal dopaminergic and cholinergic neurons has been demonstrated in response to rewarding stimuli [16] . Data from animal models investigating the effects of d-amphetamine on responding for conditioned reinforcers [21- 23] support a role for phasic dopaminergic activation in enhancing response to rewardrelated stimuli. Based on these animal data, we postulate that effect of nicotine to enhance responding for positive response cues may be mediated via dopamine or acetylcholine-dependent mechanisms in mesocorticolimbic regions. Future studies will be required to test this hypothesis.
Nicotine did not significantly modulate discriminability on the task, indicating that effects on response bias were not mediated by improvement in attention or general task performance. Furthermore, if the effect of nicotine on response bias described were primarily due to improvement in attention and overall vigilance, we would expect improved accuracy for both types of stimuli presented in the task rather than differentially increased responding for the stimulus associated with the more frequent reward at the expense of accuracy for the lean stimulus, as observed. In addition, reaction time was faster on nicotine due to an expected improvement in motor speed. However, the signal detection task measures the tendency to choose the more rewarded response and is independent of speed.
Importantly, a carryover effect of nicotine on reward responsiveness was observed. This is consistent with a finding in animals in which nicotine self-administration was associated with increased reward responsiveness during active use and for 36 days after removal of nicotine availability [2] . These results suggest that a single nicotine dose may have lasting effects on reward sensitivity in humans, potentially through its effects on incentive or motivational salience, which may contribute to repeated use and the development of dependence.
The study was conducted in non-smokers to avoid confounding effects of nicotine use on reward responsiveness [2, 24] . Although the observed effect of nicotine on reward responsivity was small, it is possible that even a small enhancement in sensitivity to rewarding environmental stimuli may be sufficient to reinforce smoking behavior in vulnerable individuals. Additionally, nicotine delivered by smoke would have faster pharmacokinetics and may have a greater effect on responsivity to reward than that observed for transdermal nicotine. There are limitations to our study that require specific mention. Participants had quite low levels of depressive symptoms as indicated by low BDI scores, limiting our ability to assess clinical correlates of response bias development.
The findings of this study may however have relevance for those with disorders of hedonic tone such as anxiety, depressive disorders or schizophrenia who also have high rates of smoking [25] [26] [27] . These individuals may be particularly vulnerable to become nicotine dependent if they experience a reduction in anhedonia when they smoke. Future studies investigating generalizability of the present findings to those with disorders of hedonic tone are warranted.
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